Source: DGNews  |  Posted 8 years ago

By Peggy Peck

ORLANDO, FL -- November 12, 2003 -- In a head-to-head trial comparing moderate with aggressive statin therapy aimed at lowering levels of low-density lipoprotein (LDL) to below 80 mg/dL in patients with symptomatic coronary artery disease (CAD), aggressive treatment stopped progression of plaque burden, as measured by intravascular ultrasound (IVUS).

Principal investigator Steven E. Nissen, MD, Cleveland Clinic Foundation, Cleveland, Ohio, United States, presented these results, from the Reversal of Atherosclerosis with Lipitor